Wayne A. Marasco, M.D., Ph.D.
Title Professor of Medicine Institution Dana-Farber Cancer Institute Address Dana Farber Cancer Institute 450 Brookline Ave. Boston MA 02215
|
|

Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
R01AI161152
(MARASCO, WAYNE A.)
Sep 17, 2021 - Aug 31, 2024
Serologic and Molecular Studies of human anti-hCoV antibody cross-immunity and protective responses among endemic HCoVs and SARS-CoV2
Role: Principal Investigator
-
R01AI152209
(ESVELT, KEVIN ;JAENISCH, RUDOLF ;MARASCO, WAYNE A.;MARKOULAKI, STYLIANI ;TELFORD, SAM R)
Sep 1, 2021 - Aug 31, 2026
Heritable immunization of the white-footed mouse reservoir of Lyme disease
Role: Co-Principal Investigator
-
R21AI142502
(MARASCO, WAYNE A.)
Aug 1, 2019 - Jul 31, 2021
The role of Ig Polymorphism in shaping the Broadly Neutralizing Antibody Response to Hemagglutinin HA stem domain(s) of Influenza A, Group 1 and 2 Viruses
Role: Principal Investigator
-
R21AI142590
(WATSON, COREY TAYLOR)
Nov 15, 2018 - Oct 31, 2020
Population level characterization of human immunoglobulin heavy chain germline variants with impacts on variability in the Ab repertoire of healthy adults
Role: Co-Principal Investigator
-
R01AI121285
(MARASCO, WAYNE A.)
Nov 9, 2015 - Oct 31, 2020
Studies of IGHV Germline Gene Polymorphism, Utilization & Shifting for Seasonal Influenza Vaccine Induced Broadly Neutralizing Antibody Responses
Role: Principal Investigator
-
R56AI109223
(MARASCO, WAYNE A.)
Sep 11, 2014 - Aug 31, 2016
Structural Requirements for Broadly Protecting Antibodies to Influenza A & B
Role: Principal Investigator
-
R21AI091557
(MARASCO, WAYNE A.)
Jul 1, 2010 - Jun 30, 2013
Study of broadly neutralizing antibody generation to HIV gp140 in humanized mice
Role: Principal Investigator
-
R01AI085524
(MARASCO, WAYNE A.)
Jun 9, 2010 - May 31, 2016
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
Role: Principal Investigator
-
R33AI079767
(MARASCO, WAYNE A.)
Sep 15, 2008 - Aug 31, 2013
Novel Vaginal Microbicides Based On Stable AAV-Neutralizing Antibody Gene Transfe
Role: Principal Investigator
-
R21AI079767
(MARASCO, WAYNE A.)
Sep 15, 2008 - Aug 31, 2010
Novel Vaginal Microbicides Based On Stable AAV-Neutralizing Antibody Gene Transfe
Role: Principal Investigator
-
U01AI074518
(MARASCO, WAYNE A.)
Jul 15, 2007 - May 31, 2014
Human Mab Cocktails to Prevent &Treat H5N1 Avian Influenza
Role: Principal Investigator
-
R21DK072282
(MARASCO, WAYNE A.)
Sep 15, 2005 - May 31, 2008
Genetic Retargeted Human T-cells for RCC Immunotherapy
Role: Principal Investigator
-
U01AI061318
(MARASCO, WAYNE A.)
Sep 1, 2004 - Aug 31, 2010
Human Antibodies and Targeted Vaccines Against SARS-CoV
Role: Principal Investigator
-
R01CA104936
(MARASCO, WAYNE A.)
Jul 1, 2004 - Apr 30, 2010
Role of SHP-1 Deregulation in HTLV-1 Leukemogenesis
Role: Principal Investigator
-
R01AI060456
(MARASCO, WAYNE A.)
Apr 1, 2004 - Mar 31, 2010
Studies of CCR5 Conformational Heterogeneity &HIV Entry
Role: Principal Investigator
-
R01AI052829
(MARASCO, WAYNE A.)
Jul 15, 2003 - Dec 31, 2009
Human Anti-Macaque CCR5 Mabs for Passive Immunotherapy
Role: Principal Investigator
-
R21AI054268
(MARASCO, WAYNE A.)
Jun 15, 2003 - May 31, 2007
Targeting Human Cyclin T1 to Inhibit HIV-1 Replication
Role: Principal Investigator
-
R21AI053822
(MARASCO, WAYNE A.)
Sep 30, 2002 - Aug 31, 2005
Global Analysis of Transcriptional Deregulation by HIV-1
Role: Principal Investigator
-
P50CA093683
(KUPPER, THOMAS S.)
Sep 30, 2001 - Jan 31, 2014
Role: Co-Principal Investigator
-
R01AI048436
(MARASCO, WAYNE A.)
May 1, 2001 - Apr 30, 2005
Role of Grb3-3 in T-cell Activation &HIV-1 Replication
Role: Principal Investigator
-
R01RR014447
(MARASCO, WAYNE A.)
Jun 1, 1999 - May 31, 2006
HUMAN ANTITAT INTRABODY GENE THERAPY AGAINST SHIV
Role: Principal Investigator
-
R01AI041954
(MARASCO, WAYNE A.)
Apr 1, 1998 - Mar 31, 2005
GENE THERAPY BY PHENOTYPIC KNOCKOUT OF HIV CORECEPTORS
Role: Principal Investigator
-
R01AI034753
(MARASCO, WAYNE A.)
Nov 1, 1993 - Oct 31, 1997
GENE THERAPY AIDS--A RECOMBINANT ANTIBODY-BASED STRATEGY
Role: Principal Investigator
-
R29AI033802
(MARASCO, WAYNE A.)
Apr 1, 1993 - Mar 31, 1999
REPERTOIRE CLONING OF ANTI-HIV-1 GP120/GP41 ANTIBODIES
Role: Principal Investigator
-
K08CA001507
(MARASCO, WAYNE A.)
Jul 26, 1989 - Jun 30, 1992
CD23--AUTOCRINE GROWTH FACTOR AND RECEPTOR
Role: Principal Investigator
-
R01AI028785
(MARASCO, WAYNE A.)
May 1, 1989 - Jul 31, 2004
INTRACEULLULAR ANTI-TAT ANTIBODIES FOR AIDS GENE THERAPY
Role: Principal Investigator
-
P51RR000168
(FLIER, JEFFREY S)
Jun 1, 1978 - Apr 30, 2013
New England Primate Research Center Base Grant
Role: Co-Principal Investigator

Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.